AnalystsLucas WardLucas Ward's Stock Forecasts
AnalystsLucas Ward
Analyst Ranking
Bottom 4%
#4721 out of 4875 analysts
Average Return
-44.71%
Win Rate
22%4 out of 18
Risk vs Reward
Poor
Good
Lucas Ward's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | +36.99% | $2.19 | $3.00 | 2025-04-15 - 2025-05-09 | Buy |
Heartsciences IncHSCS | +16.63% | $2.94 | $3.43 | 2024-09-23 - 2025-05-09 | Buy |
Heartsciences IncHSCS | +8.86% | $3.15 | $3.43 | 2025-03-18 - 2025-05-09 | Buy |
Vivos Therapeutics IncVVOS | +3.81% | $2.89 | $3.00 | 2024-11-20 - 2025-05-09 | Buy |
Lucas Ward Analyst Color
Get additional color on Lucas Ward's coverage of popular stocks
Lucas Ward's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vivos Therapeutics IncVVOS | 3 | Buy | $6.20 | +106.67% | Maintains | 25 days ago |
Liqtech International IncLIQT | 4 | Buy | $3.40 | +141.13% | Reiterates | a month ago |
Heartsciences IncHSCS | 2 | Buy | $14.00 | +308.28% | Maintains | 2 months ago |
Aclarion IncACON | 3 | Buy | $481.00 | +6,674.65% | Maintains | 5 months ago |
Cyclo Therapeutics IncCYTH | 2 | Buy | $0.95 | +31.76% | Maintains | 8 months ago |
Vision Marine Technologies IncVMAR | 2 | Buy | $2,700.00 | +40,162.45% | Maintains | 9 months ago |
60 Degrees Pharmaceuticals IncSXTP | 1 | Buy | $28.80 | N/A | Initiates Coverage On | 2 years ago |
Shiftpixy IncPIXY | 1 | Buy | $2,160.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.